Premium
Burden of male lower urinary tract symptoms ( LUTS ) suggestive of benign prostatic hyperplasia ( BPH ) – focus on the UK
Author(s) -
Speakman Mark,
Kirby Roger,
Doyle Scott,
Ioannou Chris
Publication year - 2015
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12745
Subject(s) - lower urinary tract symptoms , medicine , quality of life (healthcare) , hyperplasia , population ageing , benign prostatic hyperplasia (bph) , urology , gynecology , prostate , epidemiology , gerontology , population , nursing , environmental health , cancer
Key Messages Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) can be bothersome and negatively impact on a patient's quality of life (QoL). As the prevalence of LUTS/BPH increases with age, the burden on the healthcare system and society may increase due to the ageing population. This review unifies literature on the burden of LUTS/BPH on patients and society, particularly in the UK. LUTS/BPH is associated with high personal and societal costs, both in direct medical costs and indirect losses in daily functioning, and through its negative impact on QoL for patients and partners. LUTS/BPH is often underdiagnosed and undertreated. Men should be encouraged to seek medical advice for this condition and should not accept it as part of ageing, while clinicians should be more active in the identification and treatment of LUTS/BPH. To assess the burden of illness and unmet need arising from lower urinary tract symptoms ( LUTS ) presumed secondary to benign prostatic hyperplasia ( BPH ) from an individual patient and societal perspective with a focus on the UK . E mbase, PubMed , the W orld H ealth O rganization, the C ochrane D atabase of S ystematic R eviews and the Y ork C entre for R eviews and D issemination were searched to identify studies on the epidemiological, humanistic or economic burden of LUTS / BPH published in English between O ctober 2001 and J anuary 2013. Data were extracted and the quality of the studies was assessed for inclusion. UK data were reported; in the absence of UK data, E uropean and USA data were provided. In all, 374 abstracts were identified, 104 full papers were assessed and 33 papers met the inclusion criteria and were included in the review. An additional paper was included in the review upon a revision in 2014. The papers show that LUTS are common in the UK , affecting ≈3% of men aged 45–49 years, rising to >30% in men aged ≥85 years. European and USA studies have reported the major impact of LUTS on quality of life of the patient and their partner. LUTS are associated with high personal and societal costs, both in direct medical costs and indirect losses in daily functioning. While treatment costs in the UK are relatively low compared with other countries, the burden on health services is still substantial. LUTS associated with BPH is a highly impactful condition that is often undertreated. LUTS / BPH have a major impact on men, their families, health services and society. Men with LUTS secondary to BPH should not simply accept their symptoms as part of ageing, but should be encouraged to consult their physicians if they have bothersome symptoms.